ES
REVBW icon

Equitec Specialists’s Revelation Biosciences Warrant REVBW Stock Holding History

Equitec Specialists’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,815
Closed -$9K – 74
2021
Q1 		$9K Sell
17,815
-24,950
-58% -$23.3K ﹤0.01% 219
2020
Q4 		$38K Buy
+42,765
New +$29.2K ﹤0.01% 176

Other funds holding REVBW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Equitec Specialists's REVBW Position: Q2 2021 in Review

Equitec Specialists sold out of Revelation Biosciences Warrant (REVBW) in Q2 2021, closing a stake of 17,815 shares — an estimated $9K sold.

Equitec Specialists first reported a position in REVBW in Q4 2020 and held it in 2 quarters. The position peaked at $38K in Q4 2020. 17 funds tracked by Wall St. Rank hold REVBW as of Q2 2021.

  • Equitec Specialists reported no remaining Revelation Biosciences Warrant position as of Q2 2021 after selling out during the quarter.
  • Equitec Specialists sold 17,815 Revelation Biosciences Warrant shares in Q2 2021, an estimated $9K.
  • Equitec Specialists first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 2 quarters.
  • Equitec Specialists's Revelation Biosciences Warrant position peaked at $38K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2021.

Based on Equitec Specialists's 13F filing for Q2 2021, filed 20 Jul 2021.